ICU Medical (ICUI)
(Delayed Data from NSDQ)
$176.74 USD
-4.53 (-2.50%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $176.84 +0.10 (0.06%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for ICU Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -29.66 | -74.29 | 103.14 | 86.87 | 101.04 |
Depreciation/Amortization & Depletion | 235.61 | 268.91 | 90.59 | 95.08 | 85.63 |
Net Change from Assets/Liabilities | -135.60 | -303.73 | 15.04 | -16.97 | -111.64 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 95.85 | 46.98 | 58.77 | 57.77 | 26.89 |
Net Cash From Operating Activities | 166.20 | -62.13 | 267.54 | 222.75 | 101.92 |
Property & Equipment | -82.39 | -89.32 | -68.32 | -85.83 | -97.28 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1,844.16 | -14.45 | 0.00 | -76.13 |
Investments | 4.22 | 33.04 | 4.72 | -3.93 | 15.25 |
Other Investing Activities | -9.78 | -9.02 | -12.63 | -8.39 | -8.73 |
Net Cash from Investing Activities | -87.95 | -1,909.47 | -90.69 | -98.14 | -166.89 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.02 | 8.79 | 9.37 | 13.19 | -10.91 |
Issuance (Repayment) of Debt | -30.65 | 1,641.31 | -0.61 | -0.36 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -9.35 | -13.06 | -25.64 | -12.88 | 0.00 |
Net Cash from Financing Activities | -35.98 | 1,637.03 | -16.87 | -0.04 | -10.91 |
Effect of Exchange Rate Changes | 3.16 | -9.48 | -3.25 | 2.85 | -0.23 |
Net Change In Cash & Equivalents | 45.44 | -344.04 | 156.73 | 127.43 | -76.11 |
Cash at Beginning of Period | 208.78 | 552.83 | 396.10 | 268.67 | 344.78 |
Cash at End of Period | 254.22 | 208.78 | 552.83 | 396.10 | 268.67 |
Diluted Net EPS | -1.23 | -3.11 | 4.74 | 4.02 | 4.69 |
Fiscal Year End for ICU Medical, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -60.88 | -39.47 | -29.66 | -12.51 | -19.75 |
Depreciation/Amortization & Depletion | 114.26 | 55.53 | 235.61 | 176.74 | 116.66 |
Net Change from Assets/Liabilities | 28.59 | 4.10 | -135.60 | -149.66 | -111.95 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 45.78 | 25.64 | 95.85 | 60.36 | 54.81 |
Net Cash From Operating Activities | 127.74 | 45.79 | 166.20 | 74.93 | 39.77 |
Property & Equipment | -34.69 | -15.41 | -82.39 | -52.48 | -31.06 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.50 | 0.50 | 4.22 | 2.92 | 2.92 |
Other Investing Activities | -5.36 | -2.95 | -9.78 | -7.74 | -4.65 |
Net Cash from Investing Activities | -39.55 | -17.86 | -87.95 | -57.30 | -32.79 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 3.07 | 0.15 | 4.02 | 4.02 | 2.23 |
Issuance (Repayment) of Debt | -26.02 | -13.00 | -30.65 | -22.93 | -15.25 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -14.29 | -14.00 | -9.35 | -9.22 | -8.72 |
Net Cash from Financing Activities | -37.23 | -26.85 | -35.98 | -28.13 | -21.73 |
Effect of Exchange Rate Changes | -2.54 | -3.88 | 3.16 | -1.10 | 1.86 |
Net Change In Cash & Equivalents | 48.43 | -2.80 | 45.44 | -11.59 | -12.90 |
Cash at Beginning of Period | 254.22 | 254.22 | 208.78 | 208.78 | 208.78 |
Cash at End of Period | 302.65 | 251.42 | 254.22 | 197.19 | 195.89 |
Diluted Net EPS | -0.88 | -1.63 | -0.71 | 0.30 | -0.41 |